- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 1/113 - General processes for the preparation of peptides by chemical modification of precursor peptides without change of the primary structure
Patent holdings for IPC class C07K 1/113
Total number of patents in this class: 558
10-year publication summary
|
40
|
47
|
57
|
37
|
40
|
36
|
52
|
45
|
37
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
25 |
| President and Fellows of Harvard College | 5792 |
21 |
| The Regents of the University of California | 18943 |
14 |
| Bristol-myers Squibb Company | 5080 |
11 |
| Amgen Inc. | 3779 |
10 |
| Genentech, Inc. | 3742 |
8 |
| Aileron Therapeutics, Inc. | 85 |
8 |
| Ajinomoto Co., Inc. | 2337 |
7 |
| The Feinstein Institute for Medical Research | 243 |
7 |
| ImmunoGen, Inc. | 405 |
7 |
| University of Washington | 2157 |
7 |
| The Trustees of the University of Pennsylvania | 4122 |
6 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
6 |
| Genzyme Corporation | 1205 |
6 |
| The Scripps Research Institute | 1364 |
6 |
| Biogen MA Inc. | 926 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
5 |
| Glytech, Inc. | 67 |
5 |
| Onkure, Inc. | 21 |
5 |
| SeaGen Inc | 554 |
5 |
| Other owners | 384 |